Generic Portal

— Research Explorer

Cross-genotype AR3-specific neutralizing antibodies confer long-term protection in injecting drug users after HCV clearance

Research output: Contribution to journal › Article › Academic › peer-review

DOI

https://doi.org/10.1016/j.jhep.2019.02.013
Final published version

Sabrina J. Merat
Camille Bru
Dorien van de Berg
Richard Molenkamp
Alexander W. Tarr
Sylvie Koekkoek
Neeltje A. Kootstra
Maria Prins
Jonathan K. Ball
Arjen Q. Bakker
Menno D. de Jong
Hergen Spits
Tim Beaumont
Janke Schinkel

Original language	English
Pages (from-to)	14-24
Journal	Journal of hepatology
Volume	71
Issue number	1
DOIs	https://doi.org/10.1016/j.jhep.2019.02.013
Publication status	Published - 2019

ID: 10971724